These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33372981)

  • 1. Hydrogen Sulfide: A Potential Therapeutic Target in the Development of Diabetic Retinopathy.
    Mohammad G; Radhakrishnan R; Kowluru RA
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):35. PubMed ID: 33372981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exogenous Hydrogen Sulfide Attenuates Cardiac Fibrosis Through Reactive Oxygen Species Signal Pathways in Experimental Diabetes Mellitus Models.
    Zheng D; Dong S; Li T; Yang F; Yu X; Wu J; Zhong X; Zhao Y; Wang L; Xu C; Lu F; Zhang W
    Cell Physiol Biochem; 2015; 36(3):917-29. PubMed ID: 26088607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of MMP-9 gene protects against the development of retinopathy in diabetic mice by preventing mitochondrial damage.
    Kowluru RA; Mohammad G; dos Santos JM; Zhong Q
    Diabetes; 2011 Nov; 60(11):3023-33. PubMed ID: 21933988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.
    Si YF; Wang J; Guan J; Zhou L; Sheng Y; Zhao J
    Br J Pharmacol; 2013 Jun; 169(3):619-31. PubMed ID: 23488985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirt1, a negative regulator of matrix metalloproteinase-9 in diabetic retinopathy.
    Kowluru RA; Santos JM; Zhong Q
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(9):5653-60. PubMed ID: 24894401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.
    Kowluru RA; Kanwar M
    Free Radic Biol Med; 2009 Jun; 46(12):1677-85. PubMed ID: 19345729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy.
    Kowluru RA; Shan Y
    Graefes Arch Clin Exp Ophthalmol; 2017 May; 255(5):955-962. PubMed ID: 28124145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen Sulfide Protects Retinal Ganglion Cells Against Glaucomatous Injury In Vitro and In Vivo.
    Liu H; Anders F; Thanos S; Mann C; Liu A; Grus FH; Pfeiffer N; Prokosch-Willing V
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5129-5141. PubMed ID: 28986598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats.
    Alshahwan H; Qabazard B; Mousa A; Chandrasekhar B; Santhosh K; Yousif MHM
    Eur J Pharmacol; 2022 Oct; 933():175265. PubMed ID: 36108734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GYY4137, an Extended-Release Hydrogen Sulfide Donor, Reduces NMDA-Induced Neuronal Injury in the Murine Retina.
    Sone K; Mori A; Sakamoto K; Nakahara T
    Biol Pharm Bull; 2018; 41(4):657-660. PubMed ID: 29607941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulfide attenuates lung ischemia-reperfusion injury through SIRT3-dependent regulation of mitochondrial function in type 2 diabetic rats.
    Jiang T; Liu Y; Meng Q; Lv X; Yue Z; Ding W; Liu T; Cui X
    Surgery; 2019 May; 165(5):1014-1026. PubMed ID: 30824287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GYY4137, a novel hydrogen sulfide-releasing molecule, likely protects against high glucose-induced cytotoxicity by activation of the AMPK/mTOR signal pathway in H9c2 cells.
    Wei WB; Hu X; Zhuang XD; Liao LZ; Li WD
    Mol Cell Biochem; 2014 Apr; 389(1-2):249-56. PubMed ID: 24374752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homocysteine Disrupts Balance between MMP-9 and Its Tissue Inhibitor in Diabetic Retinopathy: The Role of DNA Methylation.
    Mohammad G; Kowluru RA
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32150828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.
    Vadivel A; Alphonse RS; Ionescu L; Machado DS; O'Reilly M; Eaton F; Haromy A; Michelakis ED; Thébaud B
    PLoS One; 2014; 9(3):e90965. PubMed ID: 24603989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of matrix metalloproteinase-9 by epigenetic modifications and the development of diabetic retinopathy.
    Zhong Q; Kowluru RA
    Diabetes; 2013 Jul; 62(7):2559-68. PubMed ID: 23423566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.
    Kanwar M; Chan PS; Kern TS; Kowluru RA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3805-11. PubMed ID: 17652755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrelationship between activation of matrix metalloproteinases and mitochondrial dysfunction in the development of diabetic retinopathy.
    Santos JM; Tewari S; Lin JY; Kowluru RA
    Biochem Biophys Res Commun; 2013 Sep; 438(4):760-4. PubMed ID: 23891690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine and mitochondrial quality control in diabetic retinopathy.
    Malaviya P; Kowluru RA
    Eye Vis (Lond); 2024 Jan; 11(1):5. PubMed ID: 38229140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel mitochondria-targeted hydrogen sulfide (H
    Gerő D; Torregrossa R; Perry A; Waters A; Le-Trionnaire S; Whatmore JL; Wood M; Whiteman M
    Pharmacol Res; 2016 Nov; 113(Pt A):186-198. PubMed ID: 27565382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanism of Transcriptional Regulation of Matrix Metalloproteinase-9 in Diabetic Retinopathy.
    Mishra M; Flaga J; Kowluru RA
    J Cell Physiol; 2016 Aug; 231(8):1709-18. PubMed ID: 26599598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.